"Drug Combinations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.
| Descriptor ID |
D004338
|
| MeSH Number(s) |
D26.310
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Combinations".
Below are MeSH descriptors whose meaning is more specific than "Drug Combinations".
- Drug Combinations
- Adapalene, Benzoyl Peroxide Drug Combination
- Albuterol, Ipratropium Drug Combination
- Aminophylline
- Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
- Amlodipine, Valsartan Drug Combination
- Aspirin, Dipyridamole Drug Combination
- Biphasic Insulins
- Brimonidine Tartrate, Timolol Maleate Drug Combination
- Budesonide, Formoterol Fumarate Drug Combination
- Buprenorphine, Naloxone Drug Combination
- Contraceptives, Oral, Combined
- Dimenhydrinate
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Emtricitabine, Rilpivirine, Tenofovir Drug Combination
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Ezetimibe, Simvastatin Drug Combination
- Fluticasone-Salmeterol Drug Combination
- Mometasone Furoate, Formoterol Fumarate Drug Combination
- Multi-Ingredient Cold, Flu, and Allergy Medications
- Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
- Trimethoprim, Sulfamethoxazole Drug Combination
This graph shows the total number of publications written about "Drug Combinations" by people in this website by year, and whether "Drug Combinations" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 3 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 6 | 6 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 3 | 3 |
| 2020 | 0 | 6 | 6 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Combinations" by people in Profiles.
-
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer. JCO Clin Cancer Inform. 2024 Apr; 8:e2300209.
-
Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care. J Card Fail. 2023 Feb; 29(2):138-146.
-
Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 24; 71(25):830-833.
-
Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25?000 Medicare beneficiaries. Eur J Heart Fail. 2022 Sep; 24(9):1506-1515.
-
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA Cardiol. 2021 12 01; 6(12):1415-1423.
-
Adherence to Evidence-Based Therapies in Heart Failure: Deepening the Implementation Divide. JACC Heart Fail. 2021 12; 9(12):887-889.
-
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial. Eur J Heart Fail. 2021 09; 23(9):1518-1524.
-
Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization. J Card Fail. 2021 09; 27(9):1027-1030.
-
Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges. Curr Hypertens Rep. 2020 10 14; 22(11):95.
-
Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial. JACC Heart Fail. 2020 10; 8(10):859-866.